SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat…
The Federal Institute for Drugs and Medical Devices in Germany granted the Company approval to use SCI-110 in a clinical trial at the Hannover Medical School TEL AVIV, Israel, June…